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ABSTRACT
A 60-year old man with a 10-year history of multiple
system atrophy (MSA) was found in respiratory arrest.
After 4 months of respiratory support with two episodes
of septic shock, he died. Autopsy disclosed severe
atrophy of the mesencephalon, brainstem, medulla
oblongata and cerebellum. Gallyas–Braak, a-synuclein and
ubiquitin-positive inclusions in the cytoplasm of glial cells
were evident, despite the severe ischaemic damage due
to respiratory arrest and subsequent respiratory support
for 4 months. The cause of respiratory arrest was not
identified, but could be explained by the natural history of
MSA. The bereaved family, who had suspected mal-
practice, was satisfied with the explanation based on the
investigation performed by eight expert doctors, one
expert nurse, two coordinator nurses and two lawyers in
the model project promoted by the Japanese government.
In 2005, the Ministry of Health, Labor and Welfare
of Japan started a model project to investigate
medical practice associated death.
1 In ‘‘the model
project’’, a forensic pathologist, a histopathologist
and a clinical expert conduct the autopsy and
submit an autopsy report. Additionally, other
experts review the medical practices and submit
another report. In the local appraisal committee,
these doctors, the other independent doctors and
lawyers (for the patient’s side and the doctor’s
side) discuss the case with reference to the two
reports. The cause of death, the review of medical
practices and the recommendation for accident
prevention are explained to the bereaved family
and hospital persons at the same time, and the
summary of the report is disclosed.
1
This report is the first forensic autopsy report on
multiple system atrophy (MSA) for investigation
of the causes of death using the model project
promoted by the Japanese government; addition-
ally we report on the usefulness of using histo-
chemistry for diagnosis of MSA in severely
damaged brain tissue. The patient was found in
respiratory arrest in a hospital. He died 4 months
later with respiratory support. Before the autopsy,
we explained to the bereaved family that there was
a low possibility of finding the true cause of death
because of severe brain damage. However, we
found a-synuclein- and Gallyas-positive inclusions
in the glia; these are the hallmarks of MSA.
Additionally, we review on the mechanism under-
lying the respiratory arrest of MSA patients; this is
a current topic in neurology practice and will be an
important forensic topic.
CASE REPORT
A 60-year-old man was diagnosed primarily with
spinocerebellar atrophy and later with MSA
10 years ago from gait disturbance. There was no
family history of MSA. His younger sister had
cared him at home. For 4 years, he had been fed
through a gastrostomy tube and breathing was
assisted through a tracheostomy. He had hypogly-
caemia due to rapid transfer (dumping) of food to
the intestine for 1 year, and oesophageal regurgita-
tion for a month. As a result of these difficulties, he
was admitted to hospital, but staff could barely
communicate with him because of lack of eye
contact. The CT image showed severe atrophy of
the brainstem, medulla and cerebellum, with
fourth ventricular dilatation, consistent with
MSA. Forty-seven days after admission, he became
febrile, and this was thought to derive from
pneumonia resulting from the use of tracheostomy
tubing. Four days later, a nurse found him in
respiratory arrest and started resuscitation. He
regained spontaneous beating under mechanical
ventilation, with a flat electroencephalograph.
He underwent two episodes of septic shock
before he died 4 months later, with progressive
deterioration of respiration, and circulatory failure
towards the end. When he died, the sister claimed
negligence on the part of the nurse since it had
been 2 h since the last airway aspiration when
respiratory arrest occurred. Therefore, the hospital
recommended her to allow the deceased to undergo
the ‘‘model project’’ investigation.
AUTOPSY FINDINGS
A forensic pathologist, a histopathologist and an
emergency doctor performed the autopy on the thin
man with height of 165 cm and weight of 50.4 kg at
48 h postmortem. They conferred with the attend-
ing physician before the autopsy. The coordinator
nurses helped with the autopsy, appraisal processes
and the grief services. There was no abnormal
external finding, except for a mild bed sore, in the
patient who had gastrostomy and tracheostomy
tubes. The skeletal muscles appeared atrophic.
The heart (356 g) showed concentric hypertrophy
with mild focal fibrosis in left ventricular walls and
moderate coronary sclerosis. The right ventricle was
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775 g) demonstrated proportionate oedema but no pneumonia.
The thoracic cavities contained 1100 ml and 550 ml of exudates.
There was an ulcer scar at the gastric angle.
The brain (1243 g) showed severe softening and flattening
due to diffuse ischaemia. There was severe atrophy in the pons,
brainstem, medulla and cerebellum from the lower view (fig 1A),
resulting in marked dilatation of the fourth ventricle (fig 1B)
and the mesencephalic aquaduct (not shown). The whole
sections of the pons and medulla oblongata (fig 2A and B,
respectively) showed severe atrophy and neural loss compared
with those of an age-matched control (fig 2C and D,
respectively), as shown by the size and reduction in Klu ¨ver–
Barrera (KB) staining. There was severe atrophy of the
cerebellum (fig 3A), and loss of Purkinje cells (fig 3B) and
granular cells (fig 3C), as well as infiltration of Bergmann’s glias
(fig 3D). In the spine, the neuronal loss with the dorsal cord
preservation was consistent with sporadic MSA (not shown).
The histological examination showed severe and diffuse
cortex laminar necrosis with fibre gliosis, diffuse neuronal loss
and infiltration of macrophages (KB staining). These findings
were consistent with ischaemia and reperfusion injury due to
respiratory arrest, and resuscitation followed by 4 months of
being almost in the state of ‘‘respirator brain’’. The findings also
suggested occurrences of respiratory arrest other than the
documented one. Notably, Gallyas–Braak’s staining demon-
strated glial cytoplasmic inclusions in the cortex (fig 4A), basal
ganglia (fig 4B) and most of the whole brain regions examined
(not shown). Some inclusions were positive for anti-a-synuclein
(fig 4C) and anti-ubiquitin antibodies (fig 4D). The Gallyas–
Braak and a-synuclein-positive inclusions are the hallmark of
MSA.
1 8–10 The negative staining for anti-b-amyloid and anti-
tau-antibodies (not shown) excluded other a-synucleinopathies
such as Alzheimer disease.
Two neurologists submitted a clinical review report to the
local appraisal committee, and an expert nurse reported on the
review on the nursing care. On the basis of these reports based
on clinical review and autopsy, the three autopsy operators, two
neurologists, one nurse, two additional doctors and two lawyers
discussed and determined the proximal cause of death as MSA,
with the direct cause of respiratory arrest as unknown.
DISCUSSION
MSA is a sporadic neurodegenerative disorder that encompasses
olivopontocerebellar atrophy, striatonigral degeneration and
Shy–Drager syndrome.
2 MSA is characterised by cerebellar
ataxia, parkinsonism and autonomic dysfunction.
2–8 Patients
with MSA suffer from ataxia, dysarthria and dysphagia due to
degeneration of olivary neurons, pons and spinal cord. The
parkinsonisms are manifested as akinesia and muscle rigidity,
and autonomic nervous system dysfunction manifests as
postural hypotension, vocal cord paralysis and sleep apnoea.
2–8
The typical course of MSA in Japanese patients has been
reviewed, with an onset of around 55 years, the median times
from initial symptoms to combined motor and autonomic
dysfunction of 2 years, to a bedridden state of 8 years, and to
death of 9 years.
4 The histopathological hallmark is the
formation of a-synuclein-positive and Gallyas-positive argyro-
philic glial cytoplasmic inclusions.
2 9–12 The inclusions may be
also stained with ubiquitin,
9 as found in this case.
The clinical symptoms and course, marked atrophy of
medulla, brainstem, cerebellum and spinal cord, and histological
findings, supported the clinical diagnosis of sporadic MSA. The
preservation of the Gallyas–Braak and a-synuclein-positive
inclusions were unexpected as the brain showed severe and
diffuse softening due to respiratory arrest and near ‘‘respirator
brain’’ state, and the time lapse before the postmortem (48 h).
However, the immunoreactivity was preserved for a-synuclein
and ubiquitin, consistent with MSA. Aggregation of a-synuclein
underlies a-synucleinopathies including MSA, Parkinson dis-
ease, dementia with Lewy bodies (LBs), diffuse LB disease and
the LB variant of Alzheimer disease.
9–13
The direct cause of respiratory arrest was not identified.
There was no sign of ischaemia and arrhythmia on ECG or
enzyme leakage during the hospitalisation. From the appearance
of the mild myocardial lesion, the duration of the respiratory
arrest would not have been long. There were two episodes of
septic shock, but the focus of inflammation was not identified.
The lung oedema at the end-stage may have been caused by the
circulatory failure complicated by enhanced vascular perme-
ability and excessive transfusion.
The sister of the patient demanded to know whether
asphyxia due to insufficient aspiration of sputa had caused
the respiratory arrest. The nurses had not aspirated for 2 h
before the respiratory arrest. Moreover, sputa, body tempera-
ture, C-reactive protein and leucocyte count had increased over
a few days. However, asphyxia was excluded because of the
relatively small amount of the sputa aspirated from the airway.
Sleep-disordered breathing in MSA patients is known to cause
sudden death. It is hypothesised that hypoventilation may be
caused by impaired automatic control of ventilation secondary
to degeneration of the pontomedullary respiratory centres; or by
stridor and obstructive sleep apnoea due to larynx narrowing
secondary to combined vocal cord abductor paralysis and
excessive adductor activation during inspiration.
7
Figure 1 Atrophy in the midbrain, brainstem, medulla and cerebellum
from the lower view (A), and dilatation of the 4th ventricle (B).
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has confirmed severe loss of putative chemosensitive neurons,
accumulation of a-synuclein immunoreactive glial inclusions as
well as marked fibre gliosis in the medulla in cases of MSA.
10–12
Additionally, given that autonomic failure is a prominent
feature of MSA, a pathological involvement of autonomic
neurons would contribute to respiratory arrest in MSA.
34Rapid
eye movement (REM) sleep disorder occurs 90–100% of MSA
patients, indicating severe and widespread impairment in the
brainstem that regulates REM sleep.
14 In our case, the atrophy
in the brainstem and medulla was severe.
In support of the airway obstruction hypothesis, a clinical
study using laryngoscopy under anaesthesia reported vocal cord
abductor paralysis (45%) and floppy epiglottis and airway
obstruction (55%) of patients with MSA.
8 It is well known that
many patients with MSA suffer from nocturnal laryngeal
stridor attributed to paradoxical vocal cord motion (PVCM).
4
PVCM is the adduction of the vocal cords during inspiration,
and it can cause airway obstruction.
4
It has also been reported that tracheostomy can fatally
exacerbate sleep-disordered breathing in MSA, from the
observations that the apnoea–hypopnoea index becomes higher
after tracheostomy, and all patients with tracheostomies have
frequent central sleep apnoeas.
15 In an epidemiological study,
sleep apnoea is an expected event in MSA and the mean time
from the onset to death in Japanese patients is 9 years,
5 whereas
the patient in the current case had lived 11 years from the onset
of MSA. Collectively, it is reasonable to assume that he died in
the natural course of MSA.
From the point of view of the patient’s family, the sister had
cared the patient for more than 10 years at home, but she and
the attending physician were far away from the hospital when
the respiratory arrest happened. Additionally, the sister had
criticised the chief nurse on the care given by nurses with less
experience than the sister of caring for patients with MSA.
After more than 2 h, she accepted our explanation that there
was no negligence on the side of the nurse. She told me that the
family would be happy if the findings of this case were to be
disclosed in order to prevent the recurrence of similar events.
Although this is a case in which the doctors themselves found
no evidence of malpractice, but the family of the bereaved
suspected that it had occurred, the investigation was able to re-
evaluate the case independently.
The model project has been useful in the evaluation as to how
we conduct investigations into medical practice associated
deaths and explain the findings to the concerned parties.
Although the ‘‘model project’’ is useful, it is limited by the
intense effort and resources needed to deal with such cases. A
characteristic of Japanese culture is to lay the blame on a
responsible person, but in view of reluctance of the Japanese to
be reviewed by their peers, it will take time before the
investigation system can provide safety and confidence in
Figure 2 Whole sections of the pons
(A) and medulla (B) show severe atrophy
and neural loss compared with the pons
(C) and medulla (D) of an age-matched
control, as shown by the size and
reduction in Klu ¨ver–Barrera (KB) staining.
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cerebellum (A), loss of Purkinje cells (B)
and granular cells (C), and infiltration of
Bergmann’s glias (D).
Figure 4 Gallyas–Braak staining shows
cytoplasmic inclusions in the cortex (A),
and basal ganglia (B). Some inclusions
showed positive reactions with anti-a-
synuclein (C) and anti-ubiquitin antibody
(D).
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usefulness of histochemistry in confirming the diagnosis of
MSA, despite prolonged survival after hypoxic brain damage.
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Take-home messages
c Multiple system atrophy was diagnosed
immunohistochemically despite severe ischaemic brain
damage after respiratory arrest followed by 4 months
hospitalisation.
c This case was examined by the model project on the
investigation of medical practice associated deaths promoted
by the Japanese government.
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